Many expensive cancer drugs have unclear patient benefit
New cancer drugs are being launched at a rapid pace, before their long-term effectiveness for patients can be evaluated. Several years later, most of them still lack scientific evidence for actually increasing life expectancy or improving quality of life.
Read Original Article: Many expensive cancer drugs have unclear patient benefit »
